MMP-9 Inhibitors for Neurodegeneration

📖 Wiki Page

therapeutic506 wordssynced 2026-04-02

MMP-9 Inhibitors for Neurodegeneration

Introduction

<table class="infobox infobox-therapeutic">
<tr>
<th class="infobox-header" colspan="2">MMP-9 Inhibitors for Neurodegeneration</th>
</tr>
<tr>
<td class="label">Compound</td>
<td>Development Stage</td>
</tr>
<tr>
<td class="label">SB-3CT</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">Prinomastat (AG-3340)</td>
<td>Discontinued (cancer)</td>
</tr>
<tr>
<td class="label">ANDRO</td>
<td>Research compound</td>
</tr>
<tr>
<td class="label">MMPI-based designs</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">Target</td>
<td>MMP-9 (Matrix Metalloproteinase-9, Gelatinase B)</td>
</tr>
<tr>
<td class="label">Drug Class</td>
<td>Matrix metalloproteinase inhibitor</td>
</tr>
<tr>
<td class="label">Mechanism</td>
<td>Zinc-chelating or substrate mimic</td>
</tr>
<tr>
<td class="label">Selectivity</td>
<td>Broader MMPs vs. selective</td>
</tr>
</table>

Matrix Metalloproteinase-9 (MMP-9, also known as gelatinase B) is a zinc-dependent endopeptidase that degrades components of the extracellular matrix and plays important roles in tissue remodeling, synaptic plasticity, and blood-brain barrier (BBB) function. Dysregulated MMP-9 activity contributes to neurodegeneration through BBB disruption, inflammatory cell migration, and abnormal protein processing. MMP-9 inhibitors represent a therapeutic approach to restore vascular and neuronal homeostasis. [@vp2019]

MMP-9 Biology

...

MMP-9 Inhibitors for Neurodegeneration

Introduction

MMP-9 Biology

MMP-9 is encoded by the [MMP9](/genes/mmp9) gene. Key features include:

Enzyme: Zinc-dependent endopeptidase
Substrates: Collagen IV, gelatin, elastin, laminin, TNF-α, IL-1β
Expression: Neutrophils, macrophages, microglia, neurons, endothelial cells
Regulation: Tightly controlled by TIMP-1 (tissue inhibitor of metalloproteinases-1)

MMP-9 is normally expressed at low levels but is upregulated in response to inflammation, injury, and disease processes. [@rk2020]

Mechanism of Action

MMP-9 inhibitors work through enzyme inhibition and BBB protection:

Mermaid diagram (expand to render)

Key Mechanisms

BBB Protection: MMP-9 degrades tight junction proteins (claudin-5, occludin), leading to BBB disruption. Inhibitors preserve barrier integrity. [@ma2021]

Extracellular Matrix Preservation: MMP-9 degrades basement membrane components; inhibition maintains structural support for neurons and blood vessels.

Inflammation Modulation: MMP-9 cleaves and activates pro-inflammatory cytokines (TNF-α, IL-1β); inhibition reduces inflammatory signaling.

Synaptic Protection: MMP-9 is involved in synaptic remodeling; dysregulated activity contributes to synaptic dysfunction.

Therapeutic Potential

Alzheimer's Disease

MMP-9 inhibitors may benefit AD through:

Preservation of BBB integrity
Reduced neuroinflammation
Protection of neuronal connectivity
Potential effects on amyloid processing

Parkinson's Disease

MMP-9 inhibitors are relevant for PD:

BBB disruption in substantia nigra
Protection of dopaminergic neurons
Reduced neuroinflammation
Potential for disease modification

Other Applications

Stroke
Traumatic Brain Injury
[Multiple Sclerosis](/diseases/multiple-sclerosis)
[Vascular Dementia](/diseases/vascular-dementia)

Drug Development

MMP-9 inhibitors are in various stages:

Drug Properties

Side Effects

Musculoskeletal effects (class effect of MMPIs)
Tendonitis
Gastrointestinal effects
Potential for impaired wound healing

References

[Vafadar B, et al. MMP-9 in neurodegenerative diseases: pathogenetic role and therapeutic potential. J Neurochem (2019)](https://pubmed.ncbi.nlm.nih.gov/30835892/)

[Kumar R, et al. Matrix metalloproteinases in Alzheimer's disease and Parkinson's disease. Ageing Res Rev (2020)](https://pubmed.ncbi.nlm.nih.gov/32114320/)

[Mantuano E, et al. MMP-9 and blood-brain barrier disruption in neurodegeneration. Brain (2021)](https://pubmed.ncbi.nlm.nih.gov/34048163/)

[BBB Protection](/therapeutics/blood-brain-barrier-therapeutic-strategies-cbs-psp)
[Extracellular Matrix](/therapeutics/extracellular-matrix-integrin-modulator-therapy-neurodegeneration)
[Neuroinflammation](/therapeutics/neuroinflammation-modulation-therapies)
[MMP9 Gene](/genes/mmp9)

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

[Nutrient-Sensing Epigenetic Circuit Reactivation](/hypothesis/h-4bb7fd8c) — 0.79 · Target: SIRT1
[CYP46A1 Overexpression Gene Therapy](/hypothesis/h-2600483e) — 0.79 · Target: CYP46A1
[Circadian Glymphatic Entrainment via Targeted Orexin Receptor Modulation](/hypothesis/h-9e9fee95) — 0.77 · Target: HCRTR1/HCRTR2
[Selective Acid Sphingomyelinase Modulation Therapy](/hypothesis/h-de0d4364) — 0.77 · Target: SMPD1
[Membrane Cholesterol Gradient Modulators](/hypothesis/h-9d29bfe5) — 0.76 · Target: ABCA1/LDLR/SREBF2
[Microbial Inflammasome Priming Prevention](/hypothesis/h-e7e1f943) — 0.76 · Target: NLRP3, CASP1, IL1B, PYCARD
[Blood-Brain Barrier SPM Shuttle System](/hypothesis/h-959a4677) — 0.75 · Target: TFRC
[Purinergic Signaling Polarization Control](/hypothesis/h-0758b337) — 0.74 · Target: P2RY1 and P2RX7

Related Analyses:

[Selective vulnerability of entorhinal cortex layer II neurons in AD](/analysis/SDA-2026-04-01-gap-004) 🔄
[Selective vulnerability of entorhinal cortex layer II neurons in AD](/analysis/SDA-2026-04-01-gap-004) 🔄
[4R-tau strain-specific spreading patterns in PSP vs CBD](/analysis/SDA-2026-04-01-gap-005) 🔄
[4R-tau strain-specific spreading patterns in PSP vs CBD](/analysis/SDA-2026-04-01-gap-005) 🔄
[TDP-43 phase separation therapeutics for ALS-FTD](/analysis/SDA-2026-04-01-gap-006) 🔄

📖 View canonical wiki page →

MMP-9 Inhibitors for Neurodegeneration

MMP-9 Inhibitors for Neurodegeneration

Introduction

MMP-9 Biology

MMP-9 Inhibitors for Neurodegeneration

Introduction

MMP-9 Biology

Mechanism of Action

Key Mechanisms

Therapeutic Potential

Alzheimer's Disease

Parkinson's Disease

Other Applications

Drug Development

Drug Properties

Side Effects

References

Related Pages

Related Hypotheses